Debiopharm Investment SA acquires famous Parisian restaurants in partnership with GROUPE BERTRAND and Galiena Capital

Lausanne, Switzerland – April 15, 2016 – Debiopharm Investment SA (Debiopharm) today announces an investment alongside Galiena Capital in a portfolio of renowned Parisian « Grandes Brasseries » (Le Procope, La Lorraine, Le Grand Café Capucines, Au Pied de Cochon, Flora Danica, Copenhague Champs-Élysées), through an operational partnership with GROUPE BERTRAND.

So far part of Groupe Frères Blanc, these restaurants hold a very special place in the French culinary landscape and will join Angelina, Brasserie Lipp, La Gare or Brasserie Auteuil in the portfolio of distinguished institutions managed by GROUPE BERTRAND.

Through this first investment in the catering sector and the second overall alongside Galiena Capital, Debiopharm Investment continues to develop its private equity portfolio successfully.
“We are thrilled to work with GROUPE BERTRAND and Galiena Capital, two key players both demonstrating true values and entrepreneurship spirit”, declares Thierry Mauvernay,
Co-President and Delegate of the Board of Debiopharm Group™.

About Debiopharm Investment SA
Debiopharm Investment SA pursues its mission to preserve, diversify and support the sustainable growth of Debiopharm Group, a biopharmaceutical development company based in Lausanne (Switzerland), through a comprehensive investment strategy centered on three areas of activity: Finance (portfolio management, currency hedging), Real Estate (residential and commercial) and Private Equity.

The Private Equity team focuses primarily on investment diversification, managing a portfolio of funds and of direct equity investments, as minority shareholder, in the capital of pioneering start-ups as well as small and medium-sized European companies.

Our entrepreneurial culture, as well as our willingness and capacity to act as long-term partners of the teams with which we invest, are the established pillars of our commitment.

For more information, please visit www.debiopharm.com
We are on Twitter. Follow us @DebiopharmPE at https://twitter.com/DebiopharmPE

About Galiena Capital
Galiena answers the challenges emerging from the development and transmission of French companies by accompanying executive shareholders in their growth strategy, facilitating the transfer of ownership considered by family-owned businesses or supporting spin-offs carried out by heads of group subsidiaries.
For more information about Galiena Capital, please visit http://www.galiena-capital.com/

About GROUPE BERTRAND
GROUPE BERTRAND was founded by Olivier Bertrand in 1997 when he opened his first restaurant near the Champs-Élysées in Paris.

The group has then successfully developed into three lines of business:

  • commercial catering and fast foods
  • hotels
  • beverage distribution

Among the prestigious brands managed by GROUPE BERTRAND are Burger King France, Quick, Au Bureau, Café Leffe, Angelina, Brasserie Lipp as well as the Saint James Paris and Relais Christine hotels.

GROUPE BERTRAND pursues a strategy of active growth, both organic and external, driven by a true passion for its industry and the human values it carries.

For more information about GROUPE BERTRAND, please visit http://www.groupe-bertrand.com/

Advisor
Debiopharm Investment: Gide Loyrette Nouel (Hugues Scalbert, Alexis Pailleret, Rima Maitrehenry, Bertrand Jouanneau)
Galiena Capital: Latham & Watkins (Charles-Antoine Guelluy, François-Joseph Brix), Jones Day (Florence Moulin, Emmanuel de La Rochethulon, Caroline Steil, Thomas Le Frêche)
GROUPE BERTRAND: Olswang (Christophe Gaschin, Jessica Schinkel)